Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines and quasi drugs in Japan and internationally. The company provides OTC medicines under the SEIROGAN, SEIROGAN TOI A and SEIROGAN Quick C, PISHUT OD Tablet brand names; and quasi-drugs under the RAPPA INTESTINAL REGULATOR BF brand names. It offers sanitation control products under the Cleverin PR, Cleverin Pro Stick, and Cleverin Pro name. In addition, the company manufactures and sells wood vinegar-based products. It exports its products. The company was incorporated in 1946 and is headquartered in Osaka, Japan.
Frequently asked questions
What sector does Taiko Pharmaceutical Co Ltd (4574) operate in?
Taiko Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Taiko Pharmaceutical Co Ltd (4574) current stock price?
As of the latest data, Taiko Pharmaceutical Co Ltd stock price is ¥256, with a previous close of ¥258. Taiko Pharmaceutical Co Ltd lost -¥2 in the last trading session, representing a -0.78% loss.
What is Taiko Pharmaceutical Co Ltd (4574) current market capitalization?
Taiko Pharmaceutical Co Ltd market cap is approximately 12.88 billion.
What is Taiko Pharmaceutical Co Ltd (4574) Earnings Per Share (EPS)?
The trailing EPS is ¥14, and the forward EPS is ¥5.
What is Taiko Pharmaceutical Co Ltd (4574) Price-to-Earnings (P/E) ratio?
Taiko Pharmaceutical Co Ltd current P/E ratio is 18.69, with a forward P/E of 51.2.
What is Taiko Pharmaceutical Co Ltd (4574) EBITDA?
Taiko Pharmaceutical Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 190.00 million.
Does Taiko Pharmaceutical Co Ltd (4574) pay dividends?
Yes. Taiko Pharmaceutical Co Ltd pays annual dividends with an annualized yield of 1.29% and an estimated annual payout of ¥3 per share.
When is the next ex-dividend date for Taiko Pharmaceutical Co Ltd (4574)?
The next ex-dividend date is scheduled for December 29, 2026.
What is Taiko Pharmaceutical Co Ltd (4574) beta (volatility) score?
Taiko Pharmaceutical Co Ltd has a beta of 0.051, indicating lower volatility than the overall market.
